TITLE

Effect of cyclosporin A on the allergen-induced late asthmatic reaction

AUTHOR(S)
Sihra, Bhupinder S.; Kon, Onn M.; Durham, Stephen R.; Walker, Samantha; Barnes, Neil C.; Kay, A. Barry
PUB. DATE
May 1997
SOURCE
Thorax;May1997, Vol. 52 Issue 5, p447
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66296747

 

Related Articles

  • The β2 receptor and airway hyper-responsiveness: are sensory nerves involved? Page, Clive // Thorax;Sep2009, Vol. 64 Issue 9, p2 

    The article discusses the effect of β2 receptor to the health condition of asthmatic patients. It indicates when β2 agonist drugs are used during monotherapy, it triggers bronchial hyper-responsiveness (BHR) and results to an increase in the allergen-induced early and late asthmatic...

  • Allergen-Induced Inflammation. Mathison, Ronald; Morris, Katherine; Davison, Joseph S.; Befus, Dean // Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;Dec2008, Vol. 7 Issue 4, p264 

    Allergen-induced inflammation manifests as allergic asthma, dermatitis, rhinitis, conjunctivitis, food allergies, and life- threatening anaphylaxis. Allergic reactions consist of an acute phase hypersensitivity reaction and late phase inflammation. Current therapeutic strategies consist of...

  • The Effect of Inhaled Heparin on Airway Responsiveness to Histamine and Leukotriene D[sub4]. Stelmach, Iwona; Jerzynska, Joanna; Stelmach, Wlodzimierz; Majak, Pawel; Brzozowska, Agnieszka; Gorski, Pawel; Kuna, Piotr // Allergy & Asthma Proceedings;Jan/Feb2003, Vol. 24 Issue 1, p59 

    Inhaled heparin has been shown to reduce the early and late phase of asthmatic reactions and suppress an allergen-induced increase in bronchial hyperreactivity. The mechanism involved in the control of bronchial hyperreactivity in asthma by heparin is still not understood. The purpose of...

  • Inhalation of the Rho-kinase inhibitor Y-27632 reverses allergen-induced airway hyperresponsiveness after the early and late asthmatic reaction. Schaafsma, Dedmer; Bos, I. Sophie T.; Zuidhof, Annet B.; Zaagsma, Johan; Meurs, Herman // Respiratory Research;2006, Vol. 7, p121 

    Background: In guinea pigs, we have previously demonstrated that the contribution of Rho-kinase to airway responsiveness in vivo and ex vivo is enhanced after active sensitization with ovalbumin (OA). Using conscious, unrestrained OA-sensitized guina pigs, we now investigated the role of...

  • Breathe deep. Hewitt, Allison // Pharmaceutical Executive;Mar1998, Vol. 18 Issue 3, p118 

    Reports that ICOS Corp. has initiated a Phase II clinical trial of rPlatelet-activating factor-AH in patients with asthma. Aim of the study to evaluate the safety and effectiveness of the product on allergen-induced asthmatic response.

  • Prevention of multiple drug allergy by histaglobulin. Mohanty, M.; Mohapatra, S.; Pattnaik, K. P.; Swain, T. R. // Indian Journal of Pharmacology;Feb2006, Vol. 38 Issue 1, p68 

    The article examines the effectiveness of preventing multiple drug allergy by histagolubulin. Clinical trials have shown that subcutaneous administration of histaglobulin improves clinical symptoms in allergic patients. It also inhibits allergen-induced eosinophil accumulation comparable to...

  • Effects of an Eosinophil Chemotaxis Inhibitor, TAK-661, on Antigen-Induced Asthmatic Responses in Allergic Sheep. Fujimoto, K.; Tsunoda, T.; Koizumi, T.; Kubo, K. // Lung;2002, Vol. 180 Issue 3, p161 

    Eosinophils have been shown to play a role in allergen-induced airway responses. The aim in this study was to examine the effects of TAK-661, a newly developed product as a specific inhibitory agent of eosinophil chemotaxis, on antigen-induced asthmatic responses in allergic sheep model. Seven...

  • Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects. Gauvreau, Gail M.; Boulet, Louis-Philippe; Schmid-Wirlitsch, Christine; Côté, Johanne; Duong, MyLinh; Killian, Kieran J.; Milot, Joanne; Deschesnes, Francine; Strinich, Tara; Watson, Richard M.; Bredenbröker, Dirk; O'Byrne, Paul M. // Respiratory Research;Oct2011, Vol. 12 Issue 10, p1 

    Background: Phosphodiesterase 4 (PDE4) inhibitors increase intracellular cyclic adenosine monophosphate (cAMP), leading to regulation of inflammatory cell functions. Roflumilast is a potent and targeted PDE4 inhibitor. The objective of this study was to evaluate the effects of roflumilast on...

  • Anti-IgE Monoclonal Antibody (Omalizumab) in the Treatment of Atopic Asthma and Allergic Respiratory Diseases. D'Amato, Gennaro; Liccardi, Gennaro; Noschese, Paolo; Salzillo, Antonello; D'Amato, Maria; Cazzola, Mario // Current Drug Targets - Inflammation & Allergy;Sep2004, Vol. 3 Issue 3, p227 

    Since the discovery of immunoglobulin E (IgE) antibodies thirty-six years ago, our understanding of the mechanisms of allergy has improved to such an extent that we can now better differentiate allergy from non-allergic hypersensitivity, and allergic / atopic from intrinsic / nonatopic bronchial...

  • Aspirin Allergies And Asthma. Brown, Linda J.; Wilder, Shannon // Arthritis Today;Mar/Apr99, Vol. 13 Issue 2, p14 

    Reports on the allergic reactions of asthmatic people to aspirin. Side-effects of aspirin; Advice on taking pain relievers.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics